Sudden diabetes is a high risk factor for pancreatic cancer? Teach you how to prevent and diagnose

      Is Sudden Diabetes a High Risk Factor for Pancreatic Cancer?

　　Teach you how to prevent and diagnose

　　"Paying attention to early diagnosis, early warning, and moving forward are essential to improve the survival rate of patients with pancreatic cancer.

　　Early screening should be carried out for high-risk patients.

　　The so-called high-risk occupational groups, from the perspective of age, belong to an elderly disease for us.

　　Young people under the age of 30 rarely get sick.

　　If you are over 40 years old and have upper abdominal discomfort, you will be included in the monitoring range.

　　Smoking, drinking, and high-fat diet are all high risk factors for pancreatic cancer. In particular, smoking is currently the only recognized risk factor for pancreatic cancer, and the risk can increase dozens of times.

　　There are also some familial cases of pancreatic cancer. If the immediate family members have pancreatic cancer, the probability of the disease may increase by more than ten times.

　　Some basic diseases, such as sudden diabetes and sudden diabetes within 2-3 years, should be noted whether it may be pancreatic cancer.

　　Because metabolic changes can promote tumors, sudden diabetes is also a high-risk factor.

　　In addition, there are also some chronic pancreatitis with a history of pancreatitis. Repeated attacks of chronic pancreatitis may also stimulate pancreatic cancer.

　　There are also some potential cystic diseases in the pancreas, such as mucinous cystadenoma or IPMN, which is a factor that we pay attention to patients in the early stage.

　　When pancreatic cancer is suspected, it is recommended to go to a large hospital for examination. The location of the pancreas itself is relatively secret. It is difficult to find pancreatic cancer or early pancreatic cancer through traditional means, such as the most commonly used ultrasound and color ultrasound.

　　The first is that color Doppler ultrasound is a very simple method to evaluate the pancreas.

　　More professional and advanced imaging examinations, such as ct, must be carried out.

　　For pancreatic cancer, the most common and best imaging method is abdominal enhanced ct scanning, which is a first-line screening tool for pancreatic cancer.

　　The second is magnetic resonance imaging (NMR).

　　For tumors that are difficult to differentiate, enhanced MRI will also be used for further judgment.

　　The third commonly used method is endoscopic ultrasonography, which is very meaningful for the differential diagnosis of pancreatic cancer.

　　In addition, PET/CT has a certain auxiliary role in the diagnosis of pancreatic cancer, including whether there is metastasis, and judging the tumor stage, which is based on objective imaging data.

　　Finally, some common tumor blood screening indicators can also play a certain role in prompting and warning.

　　For example, the most common tumor marker used to test blood is CA199. and its elevated level is a better indicator of pancreatic cancer.

　　Those over 40 years of age who are uncomfortable can be screened for CA199 first.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW